Sartorius Corporation

Sartorius Corporation, a foreign-owned manufacturer of laboratory equipment and life sciences instrumentation headquartered in Bohemia, New York, operates as a prime contractor (100% of recent awards) selling specialized preventive maintenance, repair services, and consumables for biomedical research instruments and equipment to federal agencies on full-and-open competitive basis without set-aside designation. The company is a subsidiary of German multinational Sartorius Aktiengesellschaft and competes across its portfolio without reliance on small-business set-asides; the source identifies no SBA certifications or 8(a) status.

Sartorius's federal capability footprint centers on field maintenance, preventive maintenance plans, and repair services for proprietary live-cell analysis systems (IncuCyte S3, S5, SX5, Zoom models), biosensor platforms (Octet systems with multiple biosensor types), flow cytometry instruments (iQue Screener+), and laboratory equipment including pipette calibration systems, water purification units, and bioreactor systems. Representative work includes a $182 thousand preventive maintenance contract with the Food and Drug Administration for seven Sartorius water purification units at Bothell, Washington (awarded July 2024, running through July 2027); a $202.2 thousand purchase order from the National Institute of Allergy and Infectious Diseases for delivery of an IncuCyte SX5 HD/3CLR system package (January 2025); a $177.4 thousand Air Force Materiel Command order for a gravimetric pipette calibration system (June 2026, completing September 2027); and a $131.4 thousand sole-source delivery from the National Center for Advancing Translational Sciences for a Sartorius IncuCyte S3 HD/2CLR system with accessories (September 2022). The company also supplies consumable biosensors, kinetics buffers, and calibration reagents in volumes ranging from $10 thousand to $96 thousand per order.

Customer concentration is heavily weighted toward the Department of Health and Human Services and its research agencies. The National Institute of Allergy and Infectious Diseases leads on both volume and dollars (91 awards, $2.5 million combined potential value), followed by the National Cancer Institute (50 awards, $1.1 million), the National Center for Advancing Translational Sciences (16 awards, $478 thousand), and the Food and Drug Administration (13 awards, $567 thousand). These four agencies account for 170 awards (62% of the recent footprint) and anchor roughly two-thirds of the combined potential value. Secondary customers include the National Institute on Aging, National Institute of Diabetes and Digestive and Kidney Diseases, National Center for Advancing Translational Sciences, and peripheral defense and civilian agencies (Air Force Materiel Command, Bureau of Medicine and Surgery, Office of Naval Research, Environmental Protection Agency, National Institute of Standards and Technology). The vendor holds one task order under the General Services Administration Multiple Award Schedule.

Activity has remained stable year over year, averaging roughly 30 to 43 awards per year from 2022 through 2024, before declining to 18 awards in 2025 and 17 in 2026 to date. Eighteen awards with combined potential value of $1 million are reaching ultimate completion inside the next twenty-four months and face recompete exposure. The vendor's award portfolio is concentrated in equipment repair and maintenance (130 awards under the Maint/Repair/Rebuild Of Equipment—Instruments And Laboratory Equipment PSC) and laboratory supplies (74 awards), with smaller shares in scales and balances, drugs and biologicals, and medical equipment maintenance. Individual award values are typically modest—the majority range from $10 thousand to $50 thousand per order, with outliers such as the $215.3 thousand bioreactor installation contract with Plains Area (July 2024) and the $171.1 thousand multi-year service contract with Veterans Integrated Service Network 17 (running through December 2026). The vendor carries one identified subcontract award as a performer on a Government Scientific Source Inc. prime task order with the National Institute of Allergy and Infectious Diseases for laboratory equipment maintenance (May 2026). Sartorius competes as a prime contractor on a full-and-open, competitive basis across all cited customer agencies, with sole-source awards limited to original-equipment-manufacturer service authority where integration or proprietary compatibility requirements restrict competition to the equipment vendor itself.